Moolec Science (NASDAQ:MLEC – Get Free Report) and Cadiz (NASDAQ:CDZI – Get Free Report) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends and valuation.
Volatility & Risk
Moolec Science has a beta of -0.46, meaning that its stock price is 146% less volatile than the S&P 500. Comparatively, Cadiz has a beta of 1.82, meaning that its stock price is 82% more volatile than the S&P 500.
Institutional and Insider Ownership
0.1% of Moolec Science shares are held by institutional investors. Comparatively, 79.8% of Cadiz shares are held by institutional investors. 19.9% of Moolec Science shares are held by company insiders. Comparatively, 1.7% of Cadiz shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Moolec Science | 0 | 0 | 0 | 0 | 0.00 |
| Cadiz | 0 | 1 | 1 | 0 | 2.50 |
Cadiz has a consensus price target of $10.00, suggesting a potential upside of 121.24%. Given Cadiz’s stronger consensus rating and higher possible upside, analysts plainly believe Cadiz is more favorable than Moolec Science.
Earnings & Valuation
This table compares Moolec Science and Cadiz”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Moolec Science | $5.62 million | 0.81 | -$7.31 million | ($2.20) | -0.52 |
| Cadiz | $9.61 million | 38.58 | -$31.14 million | ($0.51) | -8.86 |
Moolec Science has higher earnings, but lower revenue than Cadiz. Cadiz is trading at a lower price-to-earnings ratio than Moolec Science, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Moolec Science and Cadiz’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Moolec Science | -105.71% | -162.27% | -25.16% |
| Cadiz | -217.49% | -97.55% | -24.76% |
Summary
Cadiz beats Moolec Science on 10 of the 14 factors compared between the two stocks.
About Moolec Science
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America. The company was founded in 2020 and is based in Luxembourg.
About Cadiz
Cadiz Inc., together with its subsidiaries, provides water solutions in the United States. The company operates through Land and Water Resources; and Water Filtration Technology segments. It offers water supply, water storage, water conveyance, and water filtration services. In addition, the company is involved in the cultivation of grain crops and alfalfa, as well as provides water filtration solutions for impaired or contaminated groundwater sources. It serves public water systems, government agencies, and other clients. Cadiz Inc. was founded in 1983 and is based in Los Angeles, California.
Receive News & Ratings for Moolec Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moolec Science and related companies with MarketBeat.com's FREE daily email newsletter.
